Article Sidebar

Download
PDF

Main Article Content

Abstract

Carbonic anhydrases, hCAs IX and XII are applied as the markers of progression of the disease in many oxygen deficient tumours and their specially manoeuvred inhibition is directly related to containing the growth of both primary tumours and tumour growth of secondary nature. Ligand-based quantitative structure-activity relationship (QSAR) studies were carried out on curcumin related, sulphonamide derivatives as inhibitors of human trans-membrane carbonic anhydrase isozyme, hCA IX by comparative molecular field similarity analysis (CoMSIA) implemented through the SYBYL package. The capacity of the model to predict coveted compound was evaluated using test set of three compounds. The best model created was found to be of choice as it showed a r2 value of 0.811 and a cross validated coefficient q2 value of 0.617 in tripos CoMSIA hydrophobic region. Results of the present study indicated that hydrophobic region factors play an important role in carbonic anhydrase hCA IX inhibition for compounds.

Keywords

3D-QSAR CoMSIA Carbonic anhydrase inhibitor Sulfonamides Isozyme hCA IX.

Article Details

License

Copyright (c) 2021 Asian Journal of Organic & Medicinal Chemistry

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite
Datta Dixit, S., & Singh, S. (2021). in silico Modeling of Curcumin Based Sulfonamides Inhibitors of the Human trans-Membrane Carbonic Anhydrase Isozyme, hCA IX by CoMSIA. Asian Journal of Organic & Medicinal Chemistry, 6(4), 306–309. https://doi.org/10.14233/ajomc.2021.AJOMC-P354
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. C.T. Supuran, Carbonic Anhydrases: Novel Therapeutic Applications for Inhibitors and Activators, Nat. Rev. Drug Discov., 7, 168 (2008); https://doi.org/10.1038/nrd2467
  2. V. Alterio, A. Di Fiore, K. D’Ambrosio, C.T. Supuran and G. De Simone, Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?, Chem. Rev., 112, 4421 (2012); https://doi.org/10.1021/cr200176r
  3. C.T. Supuran, Structure and Function of Carbonic Anhydrases, Biochem. J., 473, 2023 (2016); https://doi.org/10.1042/BCJ20160115
  4. A. Nocentini and C.T. Supuran, Carbonic Anhydrase Inhibitors as Antitumor/Antimetastatic Agents: A Patent Review (2008–2018), Expert Opin. Ther. Pat., 28, 729 (2018); https://doi.org/10.1080/13543776.2018.1508453
  5. S. Burmaoglu, A.O. Yilmaz, M.F. Polat, R. Kaya, I. Gulcin and O. Algul, Synthesis and Biological Evaluation of Phloroglucinol Derivatives Possessing a-Glycosidase, Acetylcholinesterase, Butyrylcholinesterase, Carbonic Anhydrase Inhibitory Activity, Arch. Physiol. Biochem., 43, e12908 (2019).
  6. S. Bayindir, C. Caglayan, M. Karaman and I. Gülcin, The Green Synthesis and Molecular Docking of Novel N-Substituted Rhodanines as Effective Inhibitors for Carbonic Anhydrase and Acetylcholinesterase Enzymes, Bioorg. Chem., 90, 103096 (2019); https://doi.org/10.1016/j.bioorg.2019.103096
  7. M. Boztas, P. Taslimi, M.A. Yavari, I. Gulcin, E. Sahin and A. Menzek, Synthesis and Biological Evaluation of Bromophenol Derivatives with Cyclopropyl Moiety: Ring Opening of Cyclopropane with Monoester, Bioorg. Chem., 89, 103017 (2019); https://doi.org/10.1016/j.bioorg.2019.103017
  8. C.T. Supuran, How Many Carbonic Anhydrase Inhibition Mechanisms Exist? J. Enzyme Inhib. Med. Chem., 31, 345 (2016); https://doi.org/10.3109/14756366.2015.1122001
  9. M. Sentürk, I. Gülçin, S. Beydemir, Ö.I. Küfrevioglu and C.T. Supuran, in vitro Inhibition of Human Carbonic Anhydrase I and II Isozymes with Natural Phenolic Compounds, Chem. Biol. Drug Des., 77, 494 (2011); https://doi.org/10.1111/j.1747-0285.2011.01104.x
  10. F. Carta, M. Aggarwal, A. Maresca, A. Scozzafava, R. McKenna and C.T. Supuran, Dithiocarbamates: A New Class of Carbonic Anhydrase Inhibitors. Crystallographic and Kinetic Investigations, Chem. Commun., 48, 1868 (2012); https://doi.org/10.1039/c2cc16395k
  11. E. Langella, K. D’Ambrosio, M. D’Ascenzio, S. Carradori, S.M. Monti, C.T. Supuran and G. De Simone, A Combined Crystallographic and Theoretical Study Explains the Capability of Carboxylic Acids to Adopt Multiple Binding Modes in the Active Site of Carbonic Anhydrases, Chem. Eur. J., 22, 97 (2016); https://doi.org/10.1002/chem.201503748
  12. K. D’Ambrosio, S. Carradori, S.M. Monti, M. Buonanno, D. Secci, D. Vullo, C.T. Supuran and G. De Simone, Out of the Active Site Binding Pocket for Carbonic Anhydrase Inhibitors, Chem. Commun., 51, 302 (2015); https://doi.org/10.1039/C4CC07320G
  13. R. Aditama, Y. Eryanti, D. Mujahidin, Y.M. Syah and R. Hertadi, Determination of Activities of Human Carbonic Anhydrase II Inhibitors from Curcumin Analogs, Trop. J. Pharm. Res., 16, 849 (2017); https://doi.org/10.4314/tjpr.v16i4.14
  14. N. Gencer, C. Bilen, D. Demir, A. Atahan, M. Küçükislamoglu and M. Ceylan, in vitro Inhibition Effect of Some Chalcones on Erythrocyte Carbonic Anhydrase I and II, Artif. Cells Nanomed. Biotechnol., 41, 384 (2013); https://doi.org/10.3109/21691401.2012.761226
  15. P.V. Sri Ramya, S. Angapelly, A. Angeli, C.S. Digwal, M. Arifuddin, B.N. Babu, C.T. Supuran and A. Kamal, Discovery of Curcumin Inspired Sulfonamide Derivatives as a New Class of Carbonic Anhydrase Isoforms I, II, IX, and XII Inhibitors, J. Enzyme Inhib. Med. Chem., 32, 1274 (2017); https://doi.org/10.1080/14756366.2017.1380638
  16. P. Geladi, Notes on the History and Nature of Partial Least Squares (PLS) Modelling, J. Chem., 2, 231 (1988); https://doi.org/10.1002/cem.1180020403
  17. R.D. Cramer III, J.D. Bunce, D.E. Patterson and I.E. Frank, Crossvalidation, Bootstrapping, and Partial Least Squares Compared with Multiple Regression in Conventional QSAR Studies, Quant. Struct. Act. Relat., 7, 18 (1988); https://doi.org/10.1002/qsar.19880070105